|
Name |
1,2-dihydro-acetoxydehydroaustin
|
Molecular Formula | C29H32O11 | |
IUPAC Name* |
(8-acetyloxy-2,2',2',9,13-pentamethyl-6,16-dimethylidene-6',11,15-trioxospiro[10,14,17-trioxapentacyclo[7.6.1.17,12.01,12.02,7]heptadecane-5,3'-pyran]-3-yl)acetate
|
|
SMILES |
C=C1C2(C=CC(=O)OC2(C)C)CC(OC(C)=O)C2(C)C13OC14C(=O)OC(C)(C(=C)C12C(=O)OC4C)C3OC(C)=O
|
|
InChI |
InChI=1S/C29H32O11/c1-13-24(8)20(37-17(5)31)28-14(2)26(11-10-19(32)38-23(26,6)7)12-18(36-16(4)30)25(28,9)27(13)21(33)35-15(3)29(27,40-28)22(34)39-24/h10-11,15,18,20H,1-2,12H2,3-9H3/t15-,18?,20?,24+,25?,26+,27?,28+,29-/m0/s1
|
|
InChIKey |
YQYVCCPRXKJSEE-ZQWLQCJQSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 556.56 | ALogp: | 2.0 |
HBD: | 0 | HBA: | 11 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 140.7 | Aromatic Rings: | 6 |
Heavy Atoms: | 40 | QED Weighted: | 0.282 |
Caco-2 Permeability: | -5.243 | MDCK Permeability: | 0.00004780 |
Pgp-inhibitor: | 0.991 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.874 | 20% Bioavailability (F20%): | 0.998 |
30% Bioavailability (F30%): | 0.965 |
Blood-Brain-Barrier Penetration (BBB): | 0.12 | Plasma Protein Binding (PPB): | 60.39% |
Volume Distribution (VD): | 1.491 | Fu: | 41.36% |
CYP1A2-inhibitor: | 0.002 | CYP1A2-substrate: | 0.927 |
CYP2C19-inhibitor: | 0.04 | CYP2C19-substrate: | 0.756 |
CYP2C9-inhibitor: | 0.045 | CYP2C9-substrate: | 0.02 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.035 |
CYP3A4-inhibitor: | 0.593 | CYP3A4-substrate: | 0.928 |
Clearance (CL): | 1.462 | Half-life (T1/2): | 0.008 |
hERG Blockers: | 0 | Human Hepatotoxicity (H-HT): | 0.563 |
Drug-inuced Liver Injury (DILI): | 0.961 | AMES Toxicity: | 0.949 |
Rat Oral Acute Toxicity: | 0.971 | Maximum Recommended Daily Dose: | 0.12 |
Skin Sensitization: | 0.016 | Carcinogencity: | 0.974 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.428 |
Respiratory Toxicity: | 0.713 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
D03ZZK | 0.242 | ||||||
D0H2MO | 0.241 | ||||||
D0G7KJ | 0.236 | ||||||
D0KR9U | 0.233 | ||||||
D0OL7F | 0.222 | ||||||
D09SIK | 0.214 | ||||||
D08BDT | 0.213 | ||||||
D09WYX | 0.213 | ||||||
D06XHC | 0.205 | ||||||
D01ZOG | 0.201 |